{"id":10945,"date":"2026-03-05T23:02:24","date_gmt":"2026-03-05T23:02:24","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2026\/03\/05\/omada-reports-quarterly-profit-glp1-opportunity\/"},"modified":"2026-03-05T23:02:24","modified_gmt":"2026-03-05T23:02:24","slug":"omada-reports-quarterly-profit-glp1-opportunity","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2026\/03\/05\/omada-reports-quarterly-profit-glp1-opportunity\/","title":{"rendered":"STAT+: Omada reports first profitable quarter as it seizes broad GLP-1 opportunity"},"content":{"rendered":"

STAT+: Omada reports first profitable quarter as it seizes broad GLP-1 opportunity
\n \t

\n
<\/BR>
\n
\n \t

\n
<\/BR><\/p>\n

\n

Digital chronic care company Omada reported a quarterly profit for the first time since going\u00a0 public<\/a> less than a year ago, the company revealed while announcing\u00a0 its full year 2025 earnings Thursday.\u00a0<\/p>\n

Omada also provided earnings guidance for 2026, suggesting the company will continue to grow as it capitalizes on the demand for popular GLP-1 obesity medications.<\/p>\n

Omada earned $260 million in revenue in 2025, 53% more than the year before \u2014 above top-end preliminary results the company announced<\/a> at the J.P. Morgan Healthcare Conference in January. In August, shortly after it went public, it projected<\/a> top-end earnings of $241 million for the year.<\/p>\n

Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n

\t

\n
<\/BR>
\n Mario Aguilar
\n \t

\n
<\/BR>
\nGo to statnews<\/a>
\n \t

\n
<\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"

STAT+: Omada reports first profitable quarter as it seizes broad GLP-1 opportunity Digital chronic care company Omada reported a quarterly profit for the first time since going\u00a0 public less than a year ago, the company revealed while announcing\u00a0 its full year 2025 earnings Thursday.\u00a0 Omada also provided earnings guidance for 2026, suggesting the company will […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2362,2217,2152],"tags":[2150],"class_list":["post-10945","post","type-post","status-publish","format-standard","hentry","category-chronic-disease","category-health-tech","category-stat","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/10945"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=10945"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/10945\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=10945"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=10945"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=10945"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}